Larimar Therapeutics Statistics
Total Valuation
LRMR has a market cap or net worth of $413.42 million. The enterprise value is $321.27 million.
Market Cap | 413.42M |
Enterprise Value | 321.27M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LRMR has 63.80 million shares outstanding. The number of shares has increased by 70.41% in one year.
Shares Outstanding | 63.80M |
Shares Change (YoY) | +70.41% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 84.68% |
Float | 32.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.94 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.49, with a Debt / Equity ratio of 0.07.
Current Ratio | 9.49 |
Quick Ratio | n/a |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.80% and return on invested capital (ROIC) is -47.85%.
Return on Equity (ROE) | -38.80% |
Return on Assets (ROA) | -34.30% |
Return on Capital (ROIC) | -47.85% |
Revenue Per Employee | n/a |
Profits Per Employee | -$879,738 |
Employee Count | 42 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.36% in the last 52 weeks. The beta is 0.74, so LRMR's price volatility has been lower than the market average.
Beta (1Y) | 0.74 |
52-Week Price Change | +40.36% |
50-Day Moving Average | 8.96 |
200-Day Moving Average | 5.20 |
Relative Strength Index (RSI) | 34.53 |
Average Volume (30 Days) | 654,224 |
Short Selling Information
The latest short interest is 3.63 million, so 5.69% of the outstanding shares have been sold short.
Short Interest | 3.63M |
Short Previous Month | 3.19M |
Short % of Shares Out | 5.69% |
Short % of Float | 11.22% |
Short Ratio (days to cover) | 7.49 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -41.76M |
Pretax Income | -36.95M |
Net Income | -36.95M |
EBITDA | -36.64M |
EBIT | -36.95M |
Earnings Per Share (EPS) | -$0.84 |
Balance Sheet
The company has $88.13 million in cash and $5.55 million in debt, giving a net cash position of $82.58 million or $1.29 per share.
Cash & Cash Equivalents | 88.13M |
Total Debt | 5.55M |
Net Cash | 82.58M |
Net Cash Per Share | $1.29 |
Equity / Book Value | 81.72M |
Book Value Per Share | 1.28 |
Working Capital | 80.67M |
Cash Flow
In the last 12 months, operating cash flow was -$33.46 million and capital expenditures -$164,000, giving a free cash flow of -$33.62 million.
Operating Cash Flow | -33.46M |
Capital Expenditures | -164,000 |
Free Cash Flow | -33.62M |
FCF Per Share | -$0.77 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LRMR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -70.41% |
Shareholder Yield | -70.41% |
Earnings Yield | -9.15% |
FCF Yield | -8.33% |
Analyst Forecast
The average price target for LRMR is $18.50, which is 185.05% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.50 |
Price Target Difference | 185.05% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 29, 2020. It was a reverse split with a ratio of 1:12.
Last Split Date | May 29, 2020 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |